Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Operating activities
Net income (loss) attributable to common stockholders	$ 84,492	$ 19,409	$ (27,804)
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	130,052	117,866	102,232
Stock-based compensation	90,545	88,347	105,829
Provision for expected credit losses	16,446	15,357	16,551
Operating lease right-of-use assets and liabilities, net	324	5,709	11,417
Loss on extinguishment of debt	0	0	407
Net accretion of discounts and amortization of premiums on investments	2,569	1,866	(6,135)
Non-cash interest expense	7,987	7,949	7,880
Impairment of certain long-lived assets	356	1,140	1,635
Deferred income taxes	2,337	(67)	(1,835)
Release of VAT reserve	0	(819)	0
Other	4,921	627	166
Changes in operating assets and liabilities:
Accounts receivable	(26,746)	(22,668)	(26,645)
Prepaid expenses and other current assets	(12,099)	(9,593)	(1,424)
Accounts payable and accrued expenses	7,423	(11,077)	5,500
Deferred revenue	57	(315)	(290)
Other assets and liabilities	(25,939)	21,211	7,668
Net cash provided by operating activities	282,725	234,942	195,152
Investing activities
Capital expenditures - property and equipment	(178,167)	(119,299)	(106,389)
Capital expenditures - internal-use software development	(8,356)	(5,514)	(8,913)
Purchase of intangible assets	0	0	4,915
Cash paid for acquisition of businesses, net of cash acquired	0	(99,023)	(305,170)
Cash paid for asset acquisitions	0	(2,500)	(5,400)
Purchase of marketable securities	0	(352,313)	(1,695,165)
Sales of marketable securities	0	0	19,992
Maturities of marketable securities	91,675	979,565	956,847
Purchased interest on marketable securities	0	(151)	(1,575)
Proceeds from interest on marketable securities	0	151	1,549
Proceeds from sale of equipment	43	236	981
Net cash (used in) provided by investing activities	(94,805)	401,152	(1,148,158)
Financing activities
Payment of debt issuance costs	0	0	(1,520)
Proceeds related to the issuance of common stock under equity incentive plan	13,069	38,410	11,509
Proceeds from the issuance of common stock under employee stock purchase plan	4,095	4,977	7,926
Principal repayments of finance leases	(5,475)	(2,260)	0
Employee payroll taxes paid related to net settlement of equity awards	(28,347)	(21,575)	(28,278)
Repurchase and retirement of common stock including related costs	(59,788)	(488,455)	(600,000)
Net cash used in financing activities	(76,446)	(468,903)	(610,363)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(264)	(15)	(249)
Increase (decrease) in cash, cash equivalents and restricted cash	111,210	167,176	(1,563,618)
Cash, cash equivalents and restricted cash - beginning of period	318,983	151,807	1,715,425
Cash, cash equivalents and restricted cash - end of period	430,193	318,983	151,807
Supplemental disclosures of cash flow information:
Cash paid for interest	1,048	916	475
Cash paid for taxes, net of refunds	19,667	2,723	4,567
Operating cash flows paid for operating leases	83,070	74,248	49,870
Non-cash investing and financing activities:
Capitalized stock-based compensation	2,807	1,440	1,722
Property and equipment received but not yet paid, included in Accounts payable and Accrued other expenses	55,260	4,826	15,689
Operating right-of-use assets obtained in exchange for operating lease liabilities	113,230	73,440	204,105
Finance right-of-use assets obtained in exchange for finance lease liabilities	$ 324	$ 11,938	$ 0